Publication Name	World Journal of Gastroenterology
Manuscript ID	6321
Country	Greece

Received	2013-10-13 22:57
Peer-Review Started	2013-10-15 13:57
To Make the First Decision	2013-12-04 09:04
Return for Revision	2013-12-04 21:23
Revised	2013-12-29 14:16
Second Decision	2014-03-05 14:18
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-03-05 15:19
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-04-18 14:02
Typeset the Manuscript	2014-05-07 15:17
Publish the Manuscript Online	2014-06-16 16:19

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Prognostic and predictive significance of MSI in stages Ⅱ/Ⅲ colon cancer
Manuscript Source	Invited Manuscript
All Author List	Zacharenia Saridaki, John Souglakos and Vassilis Georgoulias
Funding Agency and Grant Number
Corresponding Author	John Souglakos, MD, PhD, Department of Medical Oncology, University General Hospital of Heraklion, Voutes, PO BOX 1352, 71110 Heraklion, Crete, Greece. georgsec@med.uoc.gr
Key Words	Microsatellite instability; Stage Ⅱ; Stage Ⅲ; Colon cancer; Predictive; Prognostic
Core Tip	Adjuvant chemotherapy in patients with stage Ⅱ colon cancer is still a subject of controversy. Stage Ⅱ tumors are highly heterogeneous, with five-year relative overall survival rates ranging from 58.4% to 87.5%. Recently reported European Society for Medical Oncology guidelines suggest that microsatellite instability (MSI) should be evaluated in stage Ⅱ colorectal cancer patients in order to contribute in treatment decision-making regarding chemotherapy administration. The current report critically evaluates the prognostic and predictive impact of MSI status in patients with stage Ⅱ and stage Ⅲ colon cancer.
Publish Date	2014-06-16 16:19
Citation	Saridaki Z, Souglakos J, Georgoulias V. Prognostic and predictive significance of MSI in stages Ⅱ/Ⅲ colon cancer. World J Gastroenterol 2014; 20(22): 6809-6814
URL	http://www.wjgnet.com/1007-9327/full/v20/i22/6809.htm
DOI	10.3748/wjg.v20.i22.6809

Full Article (PDF)	WJG-20-6809.pdf
Full Article (Word)	WJG-20-6809.doc
Manuscript File	6321-Review.doc
Answering Reviewers	6321-Answering reviewers.pdf
Copyright License Agreement	6321-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	Native_Speakers.doc
Peer-review Report	6321-Peer review(s).pdf
Scientific Editor Work List	6321-Scientific editor work list.doc